Healthcare

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

Focal One Robotic HIFU procedure now covered under France’s national universal health systemReimbursement milestone allows increased patient access to Focal One…

4 months ago

Attralus Presents New Data on Its Pan-Amyloid Diagnostic Imaging Candidates at ASNC 2025

124I-evuzamitide, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis of cardiac amyloidosis in patients…

4 months ago

Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies

In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo…

4 months ago

DEA National Marijuana Embarrassment: DEA Forces VA to Import Cannabis After Blocking MMJ BioPharma Cultivation US Supply

Is the DEA the Epitome of Ineptitude?"Why is the VA importing cannabis that U.S. companies have been ready to produce…

4 months ago

Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific

Hemogenyx Pharmaceuticals Announces Manufacturing Partnership with Made Scientific to Advance HG-CT-1 CAR-T Therapy CITY OF LONDON, GB / ACCESS Newswire…

4 months ago

New Data Reveals Path to SEP-1 Success Includes Early Sepsis Risk Stratification

Study reveals how Cytovale's IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by…

4 months ago

Data published in The New England Journal of Medicine demonstrate RYBREVANT®▼(amivantamab) plus LAZCLUZE®▼ (lazertinib) could re-set survival expectations in first-line EGFR-mutated advanced lung cancer

Chemotherapy-free combination regimen has the potential to usher in new era for first-line treatment, with median overall survival projected to…

4 months ago

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5…

4 months ago

Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community

No-cost access available to qualified researchers via open-source federated data platformSAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research…

4 months ago

Housing Stabilization Providers Report Impact Following Payment Suspensions

Medicaid payment suspensions disrupt operations for Housing Stabilization providers and vulnerable clients in Minnesota. MINNEAPOLIS, MN / ACCESS Newswire /…

4 months ago